2-85556005-T-G

Variant summary

Our verdict is Benign. The variant received -14 ACMG points: 0P and 14B. BP4_StrongBP6_ModerateBA1

The NM_000821.7(GGCX):​c.618+177A>C variant causes a intron change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.513 in 152,038 control chromosomes in the GnomAD database, including 21,002 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Benign (★).

Frequency

Genomes: 𝑓 0.51 ( 21002 hom., cov: 32)

Consequence

GGCX
NM_000821.7 intron

Scores

2

Clinical Significance

Benign criteria provided, single submitter B:1

Conservation

PhyloP100: -0.0300

Publications

28 publications found
Variant links:
Genes affected
GGCX (HGNC:4247): (gamma-glutamyl carboxylase) This gene encodes an integral membrane protein of the rough endoplasmic reticulum that carboxylates glutamate residues of vitamin K-dependent proteins to gamma carboxyl glutamate, a modification that is required for their activity. The vitamin K-dependent protein substrates have a propeptide that binds the enzyme, with carbon dioxide, dioxide, and reduced vitamin K acting as co-substrates. Vitamin K-dependent proteins affect a number of physiologic processes including blood coagulation, prevention of vascular calcification, and inflammation. Allelic variants of this gene have been associated with pseudoxanthoma elasticum-like disorder with associated multiple coagulation factor deficiency. Alternative splicing results in multiple transcript variants. [provided by RefSeq, Aug 2015]
GGCX Gene-Disease associations (from GenCC):
  • body skin hyperlaxity due to vitamin K-dependent coagulation factor deficiency
    Inheritance: AR Classification: DEFINITIVE, STRONG, MODERATE, SUPPORTIVE Submitted by: G2P, Labcorp Genetics (formerly Invitae), Orphanet, Ambry Genetics
  • vitamin K-dependent clotting factors, combined deficiency of, type 1
    Inheritance: AR Classification: DEFINITIVE, STRONG, SUPPORTIVE Submitted by: Labcorp Genetics (formerly Invitae), ClinGen, Ambry Genetics, Orphanet
  • pulmonary arterial hypertension
    Inheritance: AD Classification: MODERATE Submitted by: ClinGen
  • pseudoxanthoma elasticum-like skin manifestations with retinitis pigmentosa
    Inheritance: AR Classification: SUPPORTIVE Submitted by: Orphanet

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -14 ACMG points.

BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.76).
BP6
Variant 2-85556005-T-G is Benign according to our data. Variant chr2-85556005-T-G is described in ClinVar as Benign. ClinVar VariationId is 1221805.Status of the report is criteria_provided_single_submitter, 1 stars.
BA1
GnomAd4 highest subpopulation (AFR) allele frequency at 95% confidence interval = 0.675 is higher than 0.05.

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
GGCXNM_000821.7 linkc.618+177A>C intron_variant Intron 5 of 14 ENST00000233838.9 NP_000812.2

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
GGCXENST00000233838.9 linkc.618+177A>C intron_variant Intron 5 of 14 1 NM_000821.7 ENSP00000233838.3

Frequencies

GnomAD3 genomes
AF:
0.513
AC:
77941
AN:
151920
Hom.:
20965
Cov.:
32
show subpopulations
Gnomad AFR
AF:
0.681
Gnomad AMI
AF:
0.460
Gnomad AMR
AF:
0.423
Gnomad ASJ
AF:
0.401
Gnomad EAS
AF:
0.391
Gnomad SAS
AF:
0.392
Gnomad FIN
AF:
0.457
Gnomad MID
AF:
0.440
Gnomad NFE
AF:
0.465
Gnomad OTH
AF:
0.506
We have no GnomAD4 exomes data on this position. Probably position not covered by the project.
GnomAD4 genome
AF:
0.513
AC:
78033
AN:
152038
Hom.:
21002
Cov.:
32
AF XY:
0.509
AC XY:
37856
AN XY:
74302
show subpopulations
African (AFR)
AF:
0.681
AC:
28253
AN:
41462
American (AMR)
AF:
0.422
AC:
6445
AN:
15270
Ashkenazi Jewish (ASJ)
AF:
0.401
AC:
1391
AN:
3470
East Asian (EAS)
AF:
0.391
AC:
2028
AN:
5186
South Asian (SAS)
AF:
0.393
AC:
1895
AN:
4824
European-Finnish (FIN)
AF:
0.457
AC:
4817
AN:
10536
Middle Eastern (MID)
AF:
0.449
AC:
132
AN:
294
European-Non Finnish (NFE)
AF:
0.465
AC:
31581
AN:
67976
Other (OTH)
AF:
0.508
AC:
1073
AN:
2112
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.503
Heterozygous variant carriers
0
1899
3798
5698
7597
9496
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
676
1352
2028
2704
3380
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.446
Hom.:
6125
Bravo
AF:
0.517
Asia WGS
AF:
0.438
AC:
1526
AN:
3478

ClinVar

Significance: Benign
Submissions summary: Benign:1
Revision: criteria provided, single submitter
LINK: link

Submissions by phenotype

not provided Benign:1
Jul 09, 2018
GeneDx
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
-0.76
CADD
Benign
8.9
DANN
Benign
0.77
PhyloP100
-0.030
RBP_binding_hub_radar
0.0
RBP_regulation_power_radar
1.1
Mutation Taster
=100/0
polymorphism (auto)

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.030
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs6738645; hg19: chr2-85783128; API